What are the appropriate intramuscular injection sites for hepatitis A immunoglobulin and hepatitis B immunoglobulin in adults and children based on injection volume?

Intramuscular Injection Sites for Hepatitis A and B Immunoglobulin

For hepatitis A and B immunoglobulin, inject into the deltoid or gluteal muscle in adults, and the anterolateral thigh in infants, with site selection based on injection volume—use the gluteal muscle only when large volumes require it, avoiding the central buttock region to prevent sciatic nerve injury. 1

Site Selection by Age and Volume

Infants (<12 months)

• Administer hepatitis B immunoglobulin (0.5 mL dose) intramuscularly into the anterolateral thigh as the preferred site, which provides the largest muscle mass in this age group. 2
• The deltoid can be used as an alternative site when multiple vaccines must be given simultaneously. 3

Adults

• The deltoid muscle is the preferred site for routine intramuscular immunoglobulin administration in adults. 3
• For hepatitis B immunoglobulin, adults receive 0.06 mL/kg body weight intramuscularly. 2

Large Volume Injections

• When large volumes of immune globulin must be injected (e.g., hepatitis A immunoglobulin for passive immunization), choose an appropriate muscle mass—either deltoid or gluteal—capable of accommodating substantial volume. 1
• If using the gluteal muscle, inject only into the upper outer quadrant, avoiding the central region entirely, and direct the needle anteriorly (not inferiorly or perpendicular) to minimize sciatic nerve injury risk. 3, 1

Critical Safety Considerations

Why Buttock Injection Is Generally Avoided

• The buttock should not be used routinely because of documented decreased immunogenicity with hepatitis B vaccine and rabies vaccine in adults, likely from inadvertent subcutaneous or deep fat tissue deposition. 3
• Sciatic nerve injury risk makes the buttock a suboptimal choice for routine injections. 3
• The buttock is reserved specifically for passive immunization scenarios requiring large immune globulin volumes or multiple doses. 3

Needle Selection

• Select needle length sufficient to reach muscle mass but not so long as to endanger underlying neurovascular structures or bone. 3
• For infants, a 7/8- to 1-inch, 22- to 25-gauge needle typically penetrates thigh muscle adequately. 3
• For adults receiving deltoid injections, use 1- to 1.5-inch, 20- to 25-gauge needles. 3

Administration Technique

• Aspirate before injection to confirm the needle is not in a vein or artery—if blood appears, withdraw and select a new site. 3
• Use sterile, single-use disposable needles and syringes for each injection to minimize contamination risk. 3
• Administer intramuscularly only; do not inject intravenously. 2

Timing Considerations

• For hepatitis B immunoglobulin in newborns of HBsAg-positive mothers, administer 0.5 mL intramuscularly within 12 hours of birth (efficacy decreases markedly if delayed beyond 48 hours). 2
• For postexposure prophylaxis in adults, hepatitis B immunoglobulin (0.06 mL/kg) should be given as soon as possible after exposure, ideally within 24 hours (value beyond 7 days is unclear). 2
• Hepatitis A immunoglobulin is 80-90% effective when administered within 2 weeks after HAV exposure. 1